NEFL and progressive multifocal leukoencephalopathy: The determination of NfL may permit the early detection of PML in at-risk patients, since increased sNfL levels have been observed up to 3 months before the diagnosis of PML in natalizumab and ozanimod-treated patients (Valentino et al., 2023; Quintanilla-Bordás et al., 2024).